Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training
- PMID: 16750472
- DOI: 10.1016/j.clinthera.2006.04.009
Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training
Abstract
Background: Duloxetine is a serotonin and norepinephrine reuptake inhibitor and may be useful for treating women with stress urinary incontinence (SUI) in general practice.
Objective: The objective of this study was to examine the cost-effectiveness of 2 duloxetine strategies (duloxetine alone and duloxetine after inadequate response to pelvic floor muscle training [PFMT]) compared with PFMT or no treatment for women aged>or=50 years with SUI.
Methods: A Markov model with a 3-month cycle length was developed, with a time horizon of 5 years. Incontinence severity was based on incontinence episode frequency per week (IEF/week). Four SUI health states were distinguished in the model: no SUI (0 incontinence episode [IE] per week), mild SUI (19 IEs/week), moderate SUI (10-25 IEs/week), and severe SUI (>or=26 IEs/week). Transition probabilities were calculated, based on published evidence, expert opinion, and demographic data. Outcomes were expected total societal costs and expected IEs. The analysis was performed from the societal perspective of The Netherlands, and all costs were reported in year-2002 euros. One-way sensitivity and probabilistic sensitivity analyses were performed.
Results: In the model, providing PFMT cost euro0.03/IE avoided, compared with no treatment. Duloxetine after inadequate PFMT cost euro3.81/IE avoided, compared with PFMT One-way sensitivity analyses indicated that these results were robust regarding variation in age, IEF/week, and discount rate. Below the ceiling ratio of euro3.65/IE avoided, PFMT had the highest probability of being cost-effective. With higher ceiling ratios, duloxetine after inadequate PFMT had the highest cost-effectiveness probability.
Conclusions: Treating patients with duloxetine after inadequate PFMT response yielded additional health effects in the model, but would require society in The Netherlands to pay euro3.81/IE avoided for women aged>or=50 years with SUI being treated in general practice. It is up to policy-makers to determine whether this ratio would be acceptable.
Similar articles
-
Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence.Health Technol Assess. 2010 Aug;14(40):1-188, iii-iv. doi: 10.3310/hta14400. Health Technol Assess. 2010. PMID: 20738930 Review.
-
EMG-biofeedback assisted pelvic floor muscle training is an effective therapy of stress urinary or mixed incontinence: a 7-year experience with 390 patients.Arch Gynecol Obstet. 2005 Dec;273(2):93-7. doi: 10.1007/s00404-005-0011-4. Epub 2005 Jul 6. Arch Gynecol Obstet. 2005. PMID: 16001201
-
A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.J Urol. 2005 May;173(5):1647-53. doi: 10.1097/01.ju.0000154167.90600.c6. J Urol. 2005. PMID: 15821528 Clinical Trial.
-
[Duloxetine in the treatment of urinary incontinence in women].Minerva Ginecol. 2004 Aug;56(4):349-52. Minerva Ginecol. 2004. PMID: 15377983 Review. Italian.
-
The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence.Am J Obstet Gynecol. 2004 Jul;191(1):194-7. doi: 10.1016/j.ajog.2004.03.089. Am J Obstet Gynecol. 2004. PMID: 15295364 Clinical Trial.
Cited by
-
Heterogeneity of cost estimates in health economic evaluation research. A systematic review of stress urinary incontinence studies.Int Urogynecol J. 2019 Jul;30(7):1045-1059. doi: 10.1007/s00192-018-3814-0. Epub 2019 Feb 4. Int Urogynecol J. 2019. PMID: 30715575 Free PMC article.
-
Analytic model comparing the cost utility of TVT versus duloxetine in women with urinary stress incontinence.Int Urogynecol J. 2010 Aug;21(8):977-84. doi: 10.1007/s00192-010-1132-2. Epub 2010 Mar 27. Int Urogynecol J. 2010. PMID: 20349177
-
The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jun;20(6):659-66. doi: 10.1007/s00192-009-0836-7. Epub 2009 Mar 7. Int Urogynecol J Pelvic Floor Dysfunct. 2009. PMID: 19271093
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical